Teva is committed to increasing access to high-quality healthcare for people across the globe, at every stage of life. We do this by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. The company’s line of generic and specialty treatments is backed by our impressive global development and manufacturing capabilities, ensuring the highest quality and accessibility to medicines while reducing costs. Teva’s participation in a wide range of therapeutic areas and dosage forms is empowered by a unique integration of innovative specialty and generic research. Some Facts and Figures Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. We rank among the 10 top pharmaceutical companies in the world and are active in 60 countries. 
Show more
TypePublic
HQPetah Tikva, IL
Founded1901
Size (employees)51,800 (est)-9%
Websitetevapharm.com
Teva Pharmaceuticals was founded in 1901 and is headquartered in Petah Tikva, IL
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Teva Pharmaceuticals

Richard Daniell

Richard Daniell

Executive Vice President, European Commercial
Kare Schultz

Kare Schultz

President & CEO
Iris Beck-Codner

Iris Beck-Codner

Executive Vice President, Global Brand & Communications
Hafrun Fridriksdottir

Hafrun Fridriksdottir

Executive Vice President, Global R&D
Michael Mike McClellan

Michael Mike McClellan

Executive Vice President, Chief Financial Officer
Carlo de Notaristefani

Carlo de Notaristefani

Executive Vice President, Global Operations
Show morewdxefcqufszuzezftuxetqsqxt

Teva Pharmaceuticals Office Locations

Teva Pharmaceuticals has an office in Petah Tikva
Petah Tikva, IL (HQ)
5 Basel St
Show all (1)
Report incorrect company information

Teva Pharmaceuticals Financials and Metrics

Teva Pharmaceuticals Revenue

Market capitalization (21-Sep-2018)

24.8 b

Closing stock price (21-Sep-2018)

24.4
Teva Pharmaceuticals's current market capitalization is $24.8 b.
Show all financial metrics

Teva Pharmaceuticals Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Labrys BiologicsJune 03, 2014$825 m
Report incorrect company information

Teva Pharmaceuticals Online and Social Media Presence

Embed Graph
Report incorrect company information

Teva Pharmaceuticals News and Updates

Global Primary Sclerosing Cholangitis Treatment Market 2018-2022: Key Vendors are Allergan, Glenmark, Impax Laboratories, Mylan & Teva Pharmaceuticals

DUBLIN, Sept 11, 2018 /PRNewswire/ -- The "Global Primary Sclerosing Cholangitis Treatment Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Primary Sclerosing Cholangitis Treatment Market to grow at a CAGR of 3.57% during the period 2018-2022....

Small Molecular API Market Notable Progress to Be Witnessed | Pharmaceutical Industry | Leading Players Teva Pharmaceuticals limited, Sun Pharmaceuticals Industries, Boehringer Ingelheim | Forecast up to 2027

Small Molecule API Market information presented through Market Scenario, Growth Overview, Geographical Analysis and Topmost Players spread over 110 pages. Avail the in-depth table of content (TOC) & market synopsis on MarketResearchFuture.com – Forecast till 2027. Posted via Industry Today. Foll…
Report incorrect company information

Teva Pharmaceuticals Company Life and Culture

Report incorrect company information